October Pharma S.A.E reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EGP 212.65 million compared to EGP 179.36 million a year ago. Net income was EGP 41.71 million compared to EGP 40.97 million a year ago.

Basic earnings per share from continuing operations was EGP 2.94 compared to EGP 2.88 a year ago.